Healthcare - Biotechnology - NASDAQ - US
$ 33.215
0.651 %
$ 1.89 B
Market Cap
15.74
P/E
BALANCE SHEET
811 M
ASSETS
344 M
LIABILITIES
467 M
EQUITY
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition
Harmony Biosciences Holdings, Inc.
| Current Assets | 451 M |
| Cash & Short-Term Investments | 353 M |
| Receivables | 74.1 M |
| Other Current Assets | 23.5 M |
| Non-Current Assets | 360 M |
| Long-Term Investments | 72.2 M |
| PP&E | 371 K |
| Other Non-Current Assets | 288 M |
| Current Liabilities | 164 M |
| Accounts Payable | 17.7 M |
| Short-Term Debt | 15 M |
| Other Current Liabilities | 131 M |
| Non-Current Liabilities | 181 M |
| Long-Term Debt | 179 M |
| Other Non-Current Liabilities | 2.11 M |
Balance Sheet
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | |
|---|---|---|---|---|---|---|
| ASSETS | ||||||
| Cash & Cash Equivalents | 311.7 | 243.8 | 234.3 | 228.6 | 24.5 | 83.5 |
| Short Term Investments | 41.8 | 79.3 | 0 | 0 | 0 | 0 |
| Receivables | 74.1 | 54.7 | 34.8 | 22.2 | 4.3 | 0 |
| Inventory | 5.4 | 4.3 | 4.4 | 3.8 | 1.1 | 0 |
| Other Current Assets | 18.1 | 18.1 | 10.9 | 8.3 | 1.7 | 3.2 |
| Total Current Assets | 451.1 | 400.3 | 284.4 | 262.9 | 31.5 | 86.7 |
| PP&E | 0.4 | 0.6 | 0.8 | 0.9 | 1.3 | 1.6 |
| Intangible Assets | 137.1 | 161.0 | 143.9 | 162.3 | 72.2 | 0 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments | 72.2 | 22.6 | 0.8 | 0.8 | 0.8 | 0.5 |
| Other Long Term Assets | 6.6 | 3.5 | 4.3 | 0.9 | 1.7 | 0.5 |
| Other Assets | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 811.4 | 673.9 | 433.4 | 427.1 | 106.7 | 89.3 |
| LIABILITIES | ||||||
| Accounts Payable | 17.7 | 3.8 | 1.0 | 2.6 | 6.4 | 1.5 |
| Short Term Debt | 15.0 | 2.0 | 2.0 | 0 | 0 | 0 |
| Other Current Liabilities | 131.1 | 73.1 | 50.8 | 132.0 | 13.5 | 5.8 |
| Total Current Liabilities | 163.8 | 78.9 | 53.8 | 134.5 | 19.9 | 7.2 |
| Long Term Debt | 178.6 | 189.6 | 190.0 | 194.2 | 97.9 | 324.2 |
| Deferred Tax Income | 0 | 0 | 0 | (0.2) | (0.3) | (324.5) |
| Other Liabilities | 2.1 | 2.5 | 3.2 | 1.1 | 0.5 | (323.7) |
| Total Liabilities | 344.5 | 271.0 | 246.9 | 329.9 | 118.3 | 7.8 |
| EQUITY | ||||||
| Common Stock | 1 K | 1 K | 1 K | 1 K | 1 K | 1 K |
| Retained Earnings | (143.3) | (272.1) | (453.6) | (488.2) | (422.9) | (242.7) |
| Other Accumulative Comprehensive Income/Loss | 2 K | (0.2) | 0 | (427.1) | 2 K | 2 K |
| Total Equity | 467.0 | 402.8 | 186.5 | 97.2 | (11.6) | 81.5 |
| Total Liabilities and Equity | 811.4 | 673.9 | 433.4 | 427.1 | 106.7 | 89.3 |
| SHARES OUTSTANDING | ||||||
| Common Shares Outstanding | 59.5 | 59.2 | 57.5 | 56.9 | 63.7 | 49.2 |